Benzinga's Top Downgrades

By: via Benzinga
Analysts at Morgan Stanley downgraded Gilead Sciences, Inc. (NASDAQ: GILD) from Overweight to Equal-weight. The price target for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.